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Background/Aims : Inflammation plays a key role in ischemic acute renal failure (ARF). The present study investigated 
the  infiltration  of  macrophages  in  the  early  phase  of  ischemic  ARF  in  mice. 
Methods : I schemi c AR F  w a s  i n d u c e d  b y  r e n a l  c l a m p i n g  f o r  2 2  m i n ,  w h i l e  the  control  mice  underwent  sham  surgery 
(no clamping). The serum creatinine and blood urea nitrogen (BUN) levels were measured in the control and post-ischemia 
mice. Immunofluorescence staining was used to measure the number of CD 11b-positive cells in the kidney tissue sections 
to determine the amount of post-ischemic macrophage infiltration. Lipo-Cl2MBP (clodronate) for macrophages depletion was 
injected  via  a  tail  vein  5  d  before  ischemia  induction  and  again  2  d  before  ischemia  induction. 
Results : The study found that the post-ischemia mice had higher levels of serum creatinine and BUN at 16 and 24 
h compared to the controls. Immunofluorescence staining showed there were more macrophages in the post-ischemic 
tissue at 2, 8, 16 and 24 h compared to the control tissue, and that most of these macrophages were located in the 
outer medulla. The mice treated with clodronate prior to ischemia induction were found to have lower levels of serum 
creatinine  compared  to  those  mice  that  weren’t  treated  with  clodronate. 
Conclusions : There was significant infiltration of macrophages from the early phase of ischemic ARF, and this peaked 
at  16-24  h.  Macrophage  depletion  using  clodronate  was  protective  against  ischemic  ARF.
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INTRODUCTION
Ischemia is a common cause of ARF in hospitalized patients. 
Ischemic ARF is a life threatening illness that continues to have 
a high mortality rate of 50~80% for the patients in intensive care 
settings
1). A better understanding of ischemic ARF may result in 
interventions  that  can  help  avoid  hemodialysis,  shorten  the 
course  of  ischemic  ARF  and  improve  patient  survival. 
The pathophysiology of ischemic ARF involves inflammation, in 
addition  to  the  tubular  and  vascular  factors
1).  Recent  studies 
have  indicated  the  involvement  of  leukocytes,  adhesion 
molecules,  chemokines  and  cytokines  in  ischemic  ARF
2-5). 
Specific  inflammatory  cells  release  cytokine/chemokines  that 
contribute  to  medullary  vascular  congestion  and  the  cytotoxic 
injury  to  epithelial  cells
6).  Some  studies  have  suggested  that 
neutrophils play an important role in ischemic ARF
7-9), while other 
studies have not
10, 11). Although some findings suggest the direct 
or  indirect  involvement  of  T  cells  in  ischemic  ARF
12-14),  other 
studies  have  raised  doubt  about  such  involvement
15).  It  has 
recently  been  suggested  that  macrophages  play  a  role  in 
ischemic  ARF.  It  has  been  shown  that  significant  monocyte/ 
macrophage adhesion and infiltration occurs in the outer strip of 
the outer medulla as early as 24 h post ischemic reperfusion in 
a  rat model
16, 17).  However,  there  have been  no  reports  regard-
ing the time-course infiltration of macrophages and its relation to 










































































Figure  1.  Time  course  of  the  renal  function  following  ischemia.  (A)  Blood  urea  nitrogen.  (B)  serum  creatinine  level.
The  present  study  examined  the  time-course  of  macrophage 
infiltration  in  a  mouse  model  of  ischemic  ARF.  This  study 
investigated macrophage infiltration and whether the depletion of 
macrophages  affected  ischemic  ARF. 
MATERIALS AND METHODS
Animals 
This  study  used  male  C57BL/6  mice  aged  8-10  weeks 
(Jackson  Laboratories,  Bar  Harbor,  Maine,  USA).
Ischemia  protocol 
Mice  weighing  20～25  g  each  were  anesthetized  with  an 
intraperitoneal  injection  of  Avertin  (2,2,2-tribromoethanol:  Sigma- 
Aldrich,  Milwaukee,  Wisconsin,  USA).  A  midline  incision  was 
made and the renal pedicles were bilaterally clamped for 22 min 
w i t h  u s i n g  m i c r o a n e u r y s m  c l a m p s .  T h e  c l a m p s  w e r e  t h e n  
removed  and  the  kidneys  were  observed  to  ensure  they  had 
regained  their  original  color,  which  indicated  the  restoration  of 
b l o o d  f l o w .  T h e  a b d o m e n  w a s  t h e n  c l o s e d  i n  t w o  l a y e r s .  T h e  
ischemia  time  that  was  chosen  provided  a  reversible  model  of 
ischemic ARF and it didn’t cause animal mortality. This method 
resulted in a serum creatinine peak at 24-48 h after reperfusion 
commenced,  and  the  serum  creatinine  levels  gradually  returned 
to  normal  within  5-7  d.  The  control  mice  underwent  sham 
surgery  that  consisted  of  the  same  surgical  procedure  except 
t h a t  c l a m p s  w e r e  n o t  a p p l i e d .  D u r i n g  t h e  2 4 - h  r e p e r f u s i o n  
period,  the  animals  were  kept  in  an  incubator  at  29℃.  Blood 
samples were obtained by cardiac puncture at 2, 8, 16 and 24 
h  after  surgery.  The  BUN  and  creatinine  levels  were  measured 
using an Astra Autoanalyser (Beckman Instruments Inc, Fullerton, 
California,  USA).  Each  time  point  measurement  represents  the 
mean  ±  the  standard  error  of  the  mean  (SEM)  from  6  mice.
Immunofluorescence  method
Kidney  tissues  were  embedded  in  an  optimal  cutting 
temperature  (O.C.T.);  they  were  snap-frozen  in  liquid  nitrogen 
and  then  stored  at  -80°C  until  sectioning.  The  cut  cryostat 
sections (5 µm) were fixed in 70% acetone/30% methanol for 5 
min,  air  dried  for  5  min,  rinsed  in  phosphate-buffered  solution 
(PBS) for 3 min three times, soaked in 3% paraformaldehyde for 
10  min  and  then  rinsed  in  PBS  for  3  min  three  times.  To 
determine  the  CD  11b  expression,  the  sections  were 
preincubated with 10% donkey serum for 30 min, and they were 
n e x t  i n c u b a t e d  w i t h  a n t i - m o u s e  C D  1 1 b  a n t i b o d y  ( 1 : 5 0  d i l u t i o n  
in 5% donkey serum in PBS) for 1 h at room temperature; they 
were rinsed in PBS for 5 min three times and then incubated in 
anti-donkey horseradish peroxidase (HRP) secondary antibody in 
5% donkey serum in PBS. The sections were counterstained by 
incubating them with 7:1000 Cy3, 1:1,000 wheat germ agglutinin 
and Alexa Fluor 488 conjugate (green) to identify the cytoplasm 
and they were incubated with 3:1,000 Hoechst 33,342 (blue) for 
60 mi n at  r oom t emperat ur e t o i dent i f y t he nucl eus . They wer e 
n e x t  r i n s e d  i n  P B S  f o r  5  m i n  t h r e e  t i m e s  a n d  t h e n  t h e y  w e r e  
rinsed  in  water  for  2  min;  they  were  placed  on  a  slide  with 
mounting medium and a coverslip. The fluorescent images were 
captured using a digital camera and these were merged with the 
phase-contrast  microscope  images.  To  measure  macrophage 
infiltration,  the  kidney  sections  were  stained  to  determine  the 
number  of  cells  expressing  CD  11b.  Fifteen  randomly  chosen 
high-powered fields (×400) of the corticomedullary junction were 
a s s e s s e d  b y  a  r e n a l  p a t h o l o g i s t ,  w h o  w a s  k e p t  “ b l i n d :  a s  t o  
how  the  sections  were  treated.  Tissues  from  the  control  (n=4) 
and ischemia mice (2, 8, 16 and 24 h; n=4 for each time point) 
were  examined. 
Preparation  of  liposomes
Clodronate  [dichloromethylene  bisphosphonate  (Cl2MBP)] was 
prepared according to the method of van Rooijen et al
18). Pho-
s p h a t i d y l c h o l i n e  [ 8 6  m g ;  e g g  l e c i t h i n  ( 2 0  mg / mL )  i n  c h l o r o f o r m]  
ABFigure  2.  Immunofluorescence  staining  for  CD  11b:  the  time  course.  B-F  are  representative  sections  from  2  h,  8  h,  16  h  and  24  h  ischemia, 
respectively.
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and  cholesterol  (8  mg;  8  mg/10  mL  chloroform)  were  evapora-
ted  via  rotation  under  reduced  pressure  (vacuum  pump;  Rota-
tions evaporator R-114, Buchi Labortechik, Flavil, Switzerland). A 
suspension of 2.5 g Cl2MBP in 10 mL PBS was stored under N2 
for  2  h;  this  was  sonicated  and  then  stored  overnight  at  4℃. 
The liposomes were centrifuged for 30 min (10,000 g, 4℃) and 
they  were  resuspended  in  4  mL  PBS  before  use.
In  vivo  depletion  of  macrophages 
Clodronate (100 μL/10 g mouse) was injected via a tail vein 
5  days  before  ischemia  induction  and  again  2  days  before 
ischemia  induction.  At  24  h  post-ischemic  reperfusion,  the 
mice’  blood  samples  were  analyzed  for  monocytes,  and  the 
spleens were prepared for flow cytometry as we have previously 
described
15).  Empty  liposomes,  which  did  not  containing 
clodronate,  were  prepared  in  the  same  manner  as  the  LECs, 
and the empty liposomes were used as the vehicle (V).  Staining 
was  detected  by  a  Beckton-Dickinson  FACsCalibur  (BD 
Immunocytometry  Systems,  San  Jose,  CA)  flow  cytometer. 
CellQuest Software (BD Immunocytometry Systems) was used to 
analyze  the  flow  cytometry  data  of  the  mice  that  were  treated 
w i t h  L E C s .  F o l l o w i n g  i s c h e m i a  i n d u c t i o n ,  t h e  s e r u m  c r e a t i n i n e  
levels  were  determined. 
Statistical  analyses
The  values  are  expressed  as  means±SEMs.  The  non- 
normally  distributed  data  was  analyzed  by  the  nonparametric 
unpaired  Mann-Whitney  test.  Multiple-group  comparisons  were 
p e r f o r m e d  b y  t h e  K r u s k a l - W a l l i s  t e s t  a n d  u s i n g  p o s t - t e s t s .  A  p 
value < 0.05 was considered to indicate a significant difference.
RESULTS
Time  course  of  the  serum  creatinine  and  BUN  levels 
following  ischemia
The  serum  creatinine  level  in  the  control  mice  (n=6)  was 
0 . 1 7 ± 0 . 0 3  m g / d L  a t  2 4  h  a f t e r  s h a m  s u r g e r y .  T h e  s e r u m  
creatinine  levels  at  2,  8,  16  and  24  h  from  the  ischemia  mice 
were 0.30±0.06, 0.37±0.1, 0.63±0.03 (p<0.05 vs. the control 
and  at  2  h  and  8  h  post-ischemia)  and  2.07±0.12  mg/dL 
(p<0.05 vs. the control and at 2 h, 8 h and 16 h post-ischemia) 
(n=6 for each time point), respectively. The BUN level in control 
mice  (n=6)  was  25.0±2.0  mg/dL  at  24  hr  after  sham  surgery. 
The  BUN  levels  at  2,  8,  16  and  24  h  from  the  ischemia  mice 
were 48.0±2.8, 45.6±4.2, 72.0±3.0 (p < 0.05 vs. control and 
2 h and 8 h post-ischemia) and 156.0±8.5 mg/dL (p<0.05 vs. 
the  control  and  at  2  h,  8  h  and  16  h  post-ischemia)  (n=6  for 
each  time  point),  respectively  (Figure  1A  and  1B). 
Immunofluorescence  staining  for  CD  11b  to  determine  the 
time-course  of  macrophage  infiltration  in  the  control  and 
ischemic  tissues
The number of CD 11b-postive cells in the sections from the 
control and at 2, 8, 16 and 24 h from the ischemia  mice was 
0.2±0.1,  3.5±0.3,  2.9±0.4,  13.8±1.5  and  11.3±0.7,  respec-
tively  (n=4  for  each  time  point)  (Figure  2A).  This  data  showed 
there  was  a  significant  increase  in  the  number  of  CD  11b- 
positive cells in the 2 h ischemia mice compared to the controls 
(p<0.01), and that macrophage infiltration continued to increase 
to  16-24  h  after  ischemia  was  induced.  The  representative 
s e c t i o n s  a r e  s h o w n  i n  F i g u r e s  2 B - F .
Immunofluorescence  staining  for  CD  11b  to  determine  the 
location  of  macrophages  in  the  ischemic  tissue
We determined the number of CD 11b-positive cells in various 
kidney  regions.  This  analysis  showed  there  were  1.1±0.3, 
13.2±0.9  and  1.6±0.3  CD  11b-positive  cells  in  the  24  hr 
post-ischemia sections from the cortex, outer medulla and inner 
medulla,  respectively  (p<0.01,  n=4  for  each  group,  Figure  3A). 
The  representative  images  are  shown  in  Figures  3B-D.
Renal  function  after  macrophage  depletion  with  using 
clodronate
The numbers of blood monocytes (10
6/L) were 55±18 in the 
sham-operated  mice  and  145±38  in  the  ischemic  ARF  with 
vehicle  (ARF-V)  mice  and  82±24  in  the  ischemic  ARF  with 
clodronate (ARF-LEC) mice. There was a significant decrease of 
the  blood  monocytes  in  the  ARF-LEC  mice  compared  to  the 
ARF-V mice. Administering LECs resulted in a 70% reduction of 
t h e  m a c r o p h a g e s  i n  t h e  s p l e e n  ( d a t a  n o t  s h o w n )  a n d  a  
significant  decrease  of  macrophage  infiltration  in  the  kidney  of 
the ischemic ARF mice (*p<0.01 vs. the sham operated, ARF-V 
mice, **p<0.05 vs. the sham operated mice, n=4 for each group) 
(Figure  4A).  The  representative  images  are  shown  in  Figures 
4B-D.  The  ARF-V  mice  had  higher  serum  creatinine  levels 
compared  to  the  sham  operated  mice  and  the  ARF-LEC  mice 
(0.20±0.01  vs  2.10±0.79  vs  1.09±0.67  mg/dL,  respectively, 
*p<0.05,  n=8).  The  ARF-LEC  mice  had  lower  serum  creatinine 
levels compared to the ARF-V mice (1.09±0.67 vs. 2.10±0.79 
mg/dL,  respectively,  **p<0.05,  n=8  for  each  group)  (Figure  4E). 
DISCUSSION
While t h e  previous  studies  have  indicated  that  macrophages 
play  a  role  in  ischemic  ARF,  a  causal  relation  has  yet  to  be 
reported
3).  Despite  that  the  classical  paradigms  suggest  that 
macrophages  are  involved  in  a  destructive  proinflammatory 
response,  recent  studies  have  suggested  that  macrophages Figure  3.  Immunofluorescence  staining  for  CD  11b:  its  location  in  ischemic  tissue.  B-D  show  the  representative  sections  from  the  cortex, o u t e r  
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may  be  responsible  for  restoration  of  normal  function
19).  A 
number  of  studies  have  demonstrated  that  monocytes/  macro-
phages
16, 20, 21),  as  well  as  macrophage-associated  cytokines 
s u c h  a s  I L - 1 ,  I L - 6  a n d  t r a n s f o r m i n g  g r o w t h  f a c t o r  ( T G F ) - β
21), 
and  monocyte/macrophage  chemoattractants  such  as  interferon 
(IFN) γ-inducible  protein-10,  monocyte  chemoattractant  peptides 
(MCP)-1
22-24)  and  macrophage  inflammatory  protein-2  appear  in 
the  kidney  within  2-5  days  of  ischemia-reperfusion  injury  (IRI). 
This  late  appearance  suggests  that  macrophages  may 
participate  in  the  repair  process  after  IRI.  However,  the  recent 
f i n d i n g s  b y  D a y  e t  a l .  t h a t  m a c r o p h a g e s  p l a y  a  c r i t i c a l  r o l e  i n  
mediating  the  full  extent  of  IRI  are  significant  for  the  role  of 
macrophages  in  IRI
25).  I n  a d d i t i o n ,  J o  e t  a l .  r e p o r t e d  t h a t  
macrophages  contribute  to  the  initiation  of  ischemic  ARF  in 
rats
26).  They  suggested  that  macrophages  were  an  important 
mediator  in  the  initiation  and  extension  of  ischemia/reperfusion 
injury,  and  those  strategies  that  limit  the  initial  macrophage 
infiltration  or  activation  can  be  useful  for  treating  acute  renal 
failure
26). 
The present study found that there was an increased number 
of  CD  11b-positive  cells  from  2  h  after  IRI,  and  that  macroph-
age infiltration peaked at 16-24 h. This finding is consistent with 
the recent report that ED-1 cell infiltration began to increase by 
4  h  a f t e r  I R I ,  a n d  i t  h a d  m a r k e d l y  i n c r e a s e d  b y  2 4  h .  O u r  
present  study  found  that  renal  function  was  impaired  by  16  h 
after IRI, and this impairment was maximal at 24 h. Despite the 
rapid  and  significant  recruitment  of  macrophages  from  2-8  h 
af t er  I RI  i n our st udy,  t hi s mi ght  not  be s uf f i ci ent  t o i nduce the 
deterioration  of  renal  function  during  that  time. 
The term acute tubular necrosis (ATN) is a misnomer because 
frank  tubule  cell  necrosis  is  rarely  encountered  in  human  ARF. 
Necrosis  is  inconspicuous  and  it  is  restricted  to  the  highly 
susceptible  outer  medullary  regions
6).  Even  under  normal 
conditions,  the  outer  medullary  region  exists  on  a  hypoxic 
precipice  as  a  result  of  low  blood  flow  and  the  countercurrent 
exchange  of  oxygen,  although  paradoxically,  this  outer
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medullary  region  houses  nephron  segments  with  very  high- 
energy  requirements  (e.g.,  the  S3  segment  of  the  proximal 
tubule and medullary thick ascending limb of Henle’s loop)
6). As 
such, the current study investigated the location of macrophage 
infiltration  after  ischemic  insult.  As  might  be  expected,  the 
infiltrating  macrophages  were  mainly  found  in  the  outer 
medullary  region. 
The  extension  phase  of  ischemic  ARF  involves  continued 
reduction  in  renal  perfusion,  the  ongoing  hypoxia  and  the 
inflammatory  processes  that  occur  during  reperfusion,  and  this 
all  contributes  to  continued  tubular  cell  injury.  Endothelial- 
leukocyte  interactions  mediated  through  complementary  adhe-
Figure  4.  Immunofluorescence  staining  for  CD  11b  in  the  kidney  after 
treatment  with  clodronate  (ARF-V,  ischemic  ARF  +  vehicle;  ARF-LEC, 
ischemic  ARF+clodronate).  B-D  show  the  representative  sections  from 
the sham, ARF+V and ARF+LEC mice) , respectively. E shows the renal 
function  after  macrophage  depletion. 
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sion molecules on the endothelial cells and leukocytes play a key 
role  in  the  local  accumulation  of  leukocytes,  such  as 
macrophages,  during  the  extension  phase  of  ischemic  ARF. 
Ischemic ARF leads to an increased endothelial expression of a 
variety  of  adhesion  molecules,  including  ICAM-1,  P-selectin  and 
E-selectin, which all promote endothelial-leukocyte interaction
6). A 
great deal of attention has been directed towards the peritubular 
capillary, and especially those peritubular  capillaries in  the  outer 
medullary  region
6).  The  interaction  between  adhesion  molecules 
on  the  inflamed  endothelium  and  inflammatory  cells  such  as 
macrophages  results  in  the  striking  vascular  congestion  and 
hypoperfusion  of  the  outer  medulla,  and  this  persists  even 
though the corti cal blood f low i mproves during reperfusion after 
an  ischemic  insult
2, 3).  Infiltrating  macrophages  can  also  induce 
direct  cytotoxic  effects  on  the  renal  epithelial  cells
25).  According 
t o  o u r  f i n d i n g s ,  w e  c a n  s u g g e s t  t h a t  m a c r o p h a g e  i n f i l t r a t i o n  
plays  a  pathogenic  role  in  ischemic  ARF,  and  especially  in  the 
extension  phase  of  ARF.
The  present  study  found  that  clodronate  administration 
prevented the ischemia–induced increase of the serum creatinine 
levels, and this indicated that these effects were specifically the 
result of macrophage depletion. Other investigators have shown 
that  in  an  experimental  model  of  uveitis,  liposomal 
dichloromethylene-diphosphonate  administration  depleted  the 
macrophage  component  and  it  prevented  leukocyte- endothelial 
interactions,  thus  providing  evidence  for  the  central  role  of 
macrophages  in  this  form  of  inflammation
27).  In  arterial  injury, 
macrophage  depletion  with  using  clodronate  reduced  the 
inflammation that was involved in neointimal hyperplasia
28). Those 
studies  provide  further  strong  evidence  for  the  role  of 
macrophages  in  inflammation  and  renal  ischemic  ARF.  In 
addition, two recent studies indicated that macrophage depletion 
could  protect  against  ischemic  injury
25, 26). 
In  summary,  the  present  study  of  ischemic  ARF  found  that 
there was a significant infiltration of macrophages from 2 h after 
ischemic  ARF,  that  this  infiltration  peaked  at  16-24  h,  and  that 
the macrophages were mostly in the outer medullary region. Our 
study  found  that  macrophage  depletion  using  clodronate  was 
protective  against  ischemic  ARF. 
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